Azithromycin for Treatment of Community Acquired Pneumonia Caused by Legionella pneumophila: A Retrospective Study

References

• Macfarlane JT., Finch RG., Ward MJ., Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; 2: 255–258
   PubMed Web of Science ®Google Scholar
• Marrie TD., Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1989; 11: 586–599
   PubMedGoogle Scholar
• Walder M, Svanteson B, Ursing J, Cronberg S, Johnsson T, Forsgren A. Incidence of Legionella pneumophila in acute lower respiratory tract infections. Scand J Infect Dis 1981; 13: 159–160
   PubMed Web of Science ®Google Scholar
• Friis-Møller A, Rechnitzer C, Black FT., Collins MT., Lind K, Aalund O. Prevalence of legionnaires' disease in pneumonia patients admitted to Danish department of infectious diseases. Scand J Infect Dis 1986; 18: 321–328
   PubMed Web of Science ®Google Scholar
• Fang GD., Fine M, Orloff J. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 1990; 69: 307–316
   PubMed Web of Science ®Google Scholar
• Nguyen M LT, Yu VL. Legionella infection. Clin Chest Med 1991; 12: 257–267
   PubMed Web of Science ®Google Scholar
• Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994; 18: 501–515
   PubMed Web of Science ®Google Scholar
• Miller AC. Erythromycin in legionnaires' disease: a reappraisal. J Antimicrob Chemother 1981; 7: 217–222
   PubMed Web of Science ®Google Scholar
• Mercatello A, Frappaz D, Robert D. Failure of erythromycin/rifampicin treatment of Legionella pneumophila. J Infect 1985; 10: 282–283
   PubMedGoogle Scholar
• Dorrell L, Fulton B, Ong E LC. Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease. Thorax 1994; 49: 620–621
   PubMedGoogle Scholar
• Moffie BG., Mouton RP. Sensitivity and resistance of Legionelia pneumophila to some antibiotics and combinations of antibiotics. J Antimicrob Chemother 1988; 22: 457–462
   PubMed Web of Science ®Google Scholar
• Dowling JN., Mac Devitt DA., Pasculle AW. Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and Legionella pneumophila. Antimicrob Agents Chemother 1985; 27: 272–274
   PubMedGoogle Scholar
• Arnold B, Ta A, Stout JE., Yu VL. Erythromycin, dirithromycin, azithromycin, clarithromycin, and roxithromycin activity against Legionella by broth dilution and intracellular penetration. Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FloridaUSA, October 4–7, 1994
   Google Scholar
• Fitzgeorge RB., Featherstone A SR, Baskerville A. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. J Antimicrob Chemother 1990; 25(Suppl A)101–108
   PubMedGoogle Scholar
• Garcia-de-Lomas J, Millas E, Burgos A, Colomina FJ., Savall F, Simo MJ., Gimeno C. Oral azithromycin in experimental pneumonia by Legionella pneumophila and L. micdadei. Program and abstracts of 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, October 17–20, 1993, Abstract No. 957
   Google Scholar
• Myburgh J, Nagel GJ., Petschel E. The efficacy and tolerance of three-day course of azithromycin in the treatment of community-acquired pneumonia. J Antimicrob Chemother 1993; 31(Suppl E)163–169
   PubMedGoogle Scholar
• Wilkinson HW., Fikes BJ., Cruce DD. Indirect immunofluorescence test for serodiagnosis of legionnaires' disease: evidence for serogroup diversity of legionnaires' disease bacterial antigens and for multiple specificity of human antibodies. J Clin Microbiol 1979; 9: 379–383
   PubMed Web of Science ®Google Scholar
• Edelstein PH., Meyer RD., Finegold SM. Laboratory diagnosis of legionnaires' disease. Am Rev Respir Dis 1980; 121: 317–327
   PubMedGoogle Scholar
• Ball P. The future role and importance of macrolides. J Hosp Infect 1991; 19(Suppl A)47–59
   PubMedGoogle Scholar
• Morris DL., De Souza A, Jones JA., Morgan WE. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose. Eur J Clin Microbiol Infect Dis 1991; 10: 859–861
   PubMed Web of Science ®Google Scholar
• Andrews JM., Ashby JP., Honeybourne D. Persistence of high concentrations of azithromycin in the lung following a single oral dose. Am Rev Resp Dis 1990; 141: A598
   Google Scholar
• Baldwin DR., Wise R, Andrews JM., Ashby JP., Honeybourne D. Azithromycin concentrations at sites of pulmonary infection. Eur Respir J 1990; 3: 886–890
   PubMed Web of Science ®Google Scholar
• Foulds G, Shepard RM., Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25(Suppl A)73–82
   PubMed Web of Science ®Google Scholar
• Edelstein PH., Edelstein M AC. In vitro activity of azithromycin against clinical isolates of Legionella species. Antimicrob Agents Chemother 1991; 35: 180–181
   PubMed Web of Science ®Google Scholar
• Schönwald S, Gunjača M, Kolačny-Babić L, Car V, Gošon;ev M. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J Antimicrob Chemother 1990; 25(Suppl)123–126
   PubMedGoogle Scholar
• Schönwald S, Baršon;ić B, Klinar I, Gunjača M. Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia. Scand J Infect Dis 1994; 26: 706–710
   PubMed Web of Science ®Google Scholar
• Schönwald S, Škerk V, Petričević I, Car V, Majerus-Mišon;ć Lj, Gunjača M. Comparison of 3- and 5-day courses of azithromycin in the treatment of atypical pneumonias. Eur J Clin Microbiol Infect Dis 1991; 10: 877–880
   PubMed Web of Science ®Google Scholar